Association of Plasma B-Type Natriuretic Peptide Concentrations With Longitudinal Blood Pressure Tracking in African Americans: Findings From the Jackson Heart Study
暂无分享,去创建一个
R. Vasan | Thomas J. Wang | S. Musani | E. Fox | H. Taylor | M. Steffes | T. Samdarshi | A. Bidulescu | H. Nagarajarao | Preeti Singh
[1] V. Howard,et al. Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. , 2011, American journal of hypertension.
[2] W. Pan,et al. Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer , 2011, BMC medicine.
[3] W. Roberts,et al. The editor's roundtable: Hypertension in African Americans and other non-Caucasian ethnic groups. , 2010, The American journal of cardiology.
[4] Tae Ik Kim,et al. N-Terminal Pro-B-Type Natriuretic Peptide in Overweight and Obese Patients With and Without Diabetes: An Analysis Based on Body Mass Index and Left Ventricular Geometry , 2009, Korean circulation journal.
[5] K. Fiscella,et al. Racial Disparity in Hypertension Control: Tallying the Death Toll , 2008, The Annals of Family Medicine.
[6] G. Mitchell. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. , 2008, Journal of applied physiology.
[7] W. Nichols,et al. Effects of Arterial Stiffness, Pulse Wave Velocity, and Wave Reflections on the Central Aortic Pressure Waveform , 2008, Journal of clinical hypertension.
[8] A. Richards,et al. Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use , 2007, Hypertension.
[9] J. Burnett,et al. Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy. , 2006, American journal of physiology. Heart and circulatory physiology.
[10] C. Moy,et al. Racial and Geographic Differences in Awareness, Treatment, and Control of Hypertension: The REasons for Geographic And Racial Differences in Stroke Study , 2006, Stroke.
[11] J. Hradec,et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration , 2006, Blood pressure.
[12] Nuala A Sheehan,et al. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.
[13] P. W. Leeuw,et al. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology , 2005, Fundamental & clinical pharmacology.
[14] D. Lloyd‐Jones,et al. Hypertension in adults across the age spectrum: current outcomes and control in the community. , 2005, JAMA.
[15] J. Kato,et al. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. , 2004, American journal of hypertension.
[16] G. Wambach,et al. Plasma levels of atrial natriuretic peptide are raised in essential hypertension during low and high sodium intake , 1987, Klinische Wochenschrift.
[17] M. Andrew,et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. , 2005, Ethnicity & disease.
[18] D. Levy,et al. Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.
[19] D. Levy,et al. Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study , 2003, Hypertension.
[20] H. Taylor. Establishing a foundation for cardiovascular disease research in an African-American community--the Jackson Heart Study. , 2003, Ethnicity & disease.
[21] Pedro Lozano. Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.
[22] R. Latini,et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. , 2002, Journal of cardiac failure.
[23] Daniel Levy,et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study , 2001, The Lancet.
[24] Y. Yazaki,et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. , 2001, Cardiovascular research.
[25] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Reprinted from Life Sci. 28:89-94, 1981. , 2001, Journal of the American Society of Nephrology : JASN.
[26] R. Sarzani,et al. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. , 1998, Journal of nephrology.
[27] G. Sagnella. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. , 1998, Clinical science.
[28] M. Bold. Atrial Natriuretic Factor and Brain Natriuretic Peptide Gene Expression in the Spontaneous Hypertensive Rat During Postnatal Development , 1998 .
[29] M. L. Kuroski de Bold. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development. , 1998, American journal of hypertension.
[30] T. Ishimitsu,et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. , 1996, Hypertension.
[31] B. Bruneau,et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. , 1996, Circulation.
[32] S. Turner,et al. Atrial natriuretic peptide and blood pressure in a population-based sample. , 1995, Mayo Clinic proceedings.
[33] D. Levy,et al. Hemodynamic predictors of incident hypertension. The Framingham Heart Study. , 1994, Hypertension.
[34] N. Markandu,et al. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. , 1993, Journal of human hypertension.
[35] S. Daniels,et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.
[36] T. Horio,et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. , 1992, The American journal of medicine.
[37] K. Murata,et al. Plasma levels of atrial natriuretic peptide in patients with borderline and essential hypertension. , 1988, The Tohoku journal of experimental medicine.
[38] A. Richards,et al. Correlates of plasma atrial natriuretic factor in health and hypertension. , 1987, Hypertension.
[39] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[40] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.